Evaluation of EGFR-TKIs and ICIs treatment stratification in non-small cell lung cancer using an encrypted multidimensional radiomics approach

Abstract Background Radiomics holds great potential for the noninvasive evaluation of EGFR-TKIs and ICIs responses, but data privacy and model robustness challenges limit its current efficacy and safety. This study aims to develop and validate an encrypted multidimensional radiomics approach to enha...

Full description

Saved in:
Bibliographic Details
Main Authors: Xingping Zhang, Xingting Qiu, Yue Zhang, Qingwen Lai, Yanchun Zhang, Guijuan Zhang
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Cancer Imaging
Subjects:
Online Access:https://doi.org/10.1186/s40644-025-00824-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585424711712768
author Xingping Zhang
Xingting Qiu
Yue Zhang
Qingwen Lai
Yanchun Zhang
Guijuan Zhang
author_facet Xingping Zhang
Xingting Qiu
Yue Zhang
Qingwen Lai
Yanchun Zhang
Guijuan Zhang
author_sort Xingping Zhang
collection DOAJ
description Abstract Background Radiomics holds great potential for the noninvasive evaluation of EGFR-TKIs and ICIs responses, but data privacy and model robustness challenges limit its current efficacy and safety. This study aims to develop and validate an encrypted multidimensional radiomics approach to enhance the stratification and analysis of therapeutic responses. Materials and methods This multicenter study incorporated various data types from 506 NSCLC patients, which underwent preprocessing through anonymization methods and were securely encrypted using the AES-CBC algorithm. We developed one clinical model and three radiomics models based on clinical factors and radiomics scores (RadScore) of three distinct regions to evaluate treatment response. Additionally, an integrated radiomics-clinical model was created by combining clinical factors with RadScore. The study also explored the association between different EGFR mutations and PD-1/PD-L1 expression in radiomics biomarkers. Findings The radiomics-clinical model demonstrated high performance, with AUC values as follows: EGFR (0.884), 19Del (0.894), L858R (0.881), T790M (0.900), and PD-1/PD-L1 expression (0.893) in the test set. This model outperformed both clinical and single radiomics models. Decision curve analysis further supported its superior clinical utility. Additionally, our findings suggest that the efficacy of EGFR-TKIs and ICIs therapy may not depend on detecting a singular tumor feature or cell type. Conclusion The proposed method effectively balances the level of evidence with privacy protection, enhancing the study’s validity and security. Therefore, radiomics biomarkers are expected to complement molecular biology analyses and guide therapeutic strategies for EGFR-TKIs, ICIs, and their combinations.
format Article
id doaj-art-5dee82c8426d4fc08472440a9cc62ac7
institution Kabale University
issn 1470-7330
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Cancer Imaging
spelling doaj-art-5dee82c8426d4fc08472440a9cc62ac72025-01-26T12:50:36ZengBMCCancer Imaging1470-73302025-01-0125111410.1186/s40644-025-00824-wEvaluation of EGFR-TKIs and ICIs treatment stratification in non-small cell lung cancer using an encrypted multidimensional radiomics approachXingping Zhang0Xingting Qiu1Yue Zhang2Qingwen Lai3Yanchun Zhang4Guijuan Zhang5School of Medical Information Engineering, Gannan Medical UniversityDepartment of Radiology, First Affiliated Hospital of Gannan Medical UniversitySchool of Medical Information Engineering, Gannan Medical UniversityDepartment of Respiratory and Critical Care, First Affiliated Hospital of Gannan Medical UniversityInstitute for Sustainable Industries and Liveable Cities, Victoria UniversityDepartment of Respiratory and Critical Care, First Affiliated Hospital of Gannan Medical UniversityAbstract Background Radiomics holds great potential for the noninvasive evaluation of EGFR-TKIs and ICIs responses, but data privacy and model robustness challenges limit its current efficacy and safety. This study aims to develop and validate an encrypted multidimensional radiomics approach to enhance the stratification and analysis of therapeutic responses. Materials and methods This multicenter study incorporated various data types from 506 NSCLC patients, which underwent preprocessing through anonymization methods and were securely encrypted using the AES-CBC algorithm. We developed one clinical model and three radiomics models based on clinical factors and radiomics scores (RadScore) of three distinct regions to evaluate treatment response. Additionally, an integrated radiomics-clinical model was created by combining clinical factors with RadScore. The study also explored the association between different EGFR mutations and PD-1/PD-L1 expression in radiomics biomarkers. Findings The radiomics-clinical model demonstrated high performance, with AUC values as follows: EGFR (0.884), 19Del (0.894), L858R (0.881), T790M (0.900), and PD-1/PD-L1 expression (0.893) in the test set. This model outperformed both clinical and single radiomics models. Decision curve analysis further supported its superior clinical utility. Additionally, our findings suggest that the efficacy of EGFR-TKIs and ICIs therapy may not depend on detecting a singular tumor feature or cell type. Conclusion The proposed method effectively balances the level of evidence with privacy protection, enhancing the study’s validity and security. Therefore, radiomics biomarkers are expected to complement molecular biology analyses and guide therapeutic strategies for EGFR-TKIs, ICIs, and their combinations.https://doi.org/10.1186/s40644-025-00824-wRadiomics imaging biomarkersEGFR-TKIs therapyICIs therapyPrivacy protectionNon-small cell lung cancer
spellingShingle Xingping Zhang
Xingting Qiu
Yue Zhang
Qingwen Lai
Yanchun Zhang
Guijuan Zhang
Evaluation of EGFR-TKIs and ICIs treatment stratification in non-small cell lung cancer using an encrypted multidimensional radiomics approach
Cancer Imaging
Radiomics imaging biomarkers
EGFR-TKIs therapy
ICIs therapy
Privacy protection
Non-small cell lung cancer
title Evaluation of EGFR-TKIs and ICIs treatment stratification in non-small cell lung cancer using an encrypted multidimensional radiomics approach
title_full Evaluation of EGFR-TKIs and ICIs treatment stratification in non-small cell lung cancer using an encrypted multidimensional radiomics approach
title_fullStr Evaluation of EGFR-TKIs and ICIs treatment stratification in non-small cell lung cancer using an encrypted multidimensional radiomics approach
title_full_unstemmed Evaluation of EGFR-TKIs and ICIs treatment stratification in non-small cell lung cancer using an encrypted multidimensional radiomics approach
title_short Evaluation of EGFR-TKIs and ICIs treatment stratification in non-small cell lung cancer using an encrypted multidimensional radiomics approach
title_sort evaluation of egfr tkis and icis treatment stratification in non small cell lung cancer using an encrypted multidimensional radiomics approach
topic Radiomics imaging biomarkers
EGFR-TKIs therapy
ICIs therapy
Privacy protection
Non-small cell lung cancer
url https://doi.org/10.1186/s40644-025-00824-w
work_keys_str_mv AT xingpingzhang evaluationofegfrtkisandicistreatmentstratificationinnonsmallcelllungcancerusinganencryptedmultidimensionalradiomicsapproach
AT xingtingqiu evaluationofegfrtkisandicistreatmentstratificationinnonsmallcelllungcancerusinganencryptedmultidimensionalradiomicsapproach
AT yuezhang evaluationofegfrtkisandicistreatmentstratificationinnonsmallcelllungcancerusinganencryptedmultidimensionalradiomicsapproach
AT qingwenlai evaluationofegfrtkisandicistreatmentstratificationinnonsmallcelllungcancerusinganencryptedmultidimensionalradiomicsapproach
AT yanchunzhang evaluationofegfrtkisandicistreatmentstratificationinnonsmallcelllungcancerusinganencryptedmultidimensionalradiomicsapproach
AT guijuanzhang evaluationofegfrtkisandicistreatmentstratificationinnonsmallcelllungcancerusinganencryptedmultidimensionalradiomicsapproach